Muhammad Al-Hajj

Muhammad Al-Hajj

Plus aucun poste en cours
55 ans
Health Technology
Health Services
Consumer Services

Profil

Muhammad Al-Hajj formerly worked at GSK Plc, as Senior Director-Biology & Trans Med from 2009 to 2015, Sanford Burnham Prebys Medical Discovery Institute, as VP-Drug Discovery & Translational Medicine from 2015 to 2017, Autolus Ltd., as Senior Vice President-Translational Sciences, and IO Biotech, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Al-Hajj received his doctorate degree from the University of Michigan Comprehensive Cancer Center.

Anciens postes connus de Muhammad Al-Hajj

SociétésPosteFin
IO BIOTECH, INC. Directeur Technique/Scientifique/R&D 01/01/2024
Corporate Officer/Principal 01/06/2017
GSK PLC Corporate Officer/Principal 01/04/2015
Corporate Officer/Principal -
Voir l'expérience en détail de Muhammad Al-Hajj

Formation de Muhammad Al-Hajj

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

54

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Health Technology

Health Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Muhammad Al-Hajj
🔇